Cargando…

Comparison of Clinical Laboratory Standards Institute (CLSI) Microdilution Method and VITEK 2 Automated Antifungal Susceptibility System for the Determination of Antifungal Susceptibility of Candida Species

Introduction Changes in the epidemiology of Candida infections, increasing resistance, and advances in treatment have increased the need to perform antifungal susceptibility testing in clinical laboratories. Standardized reference, the microbroth dilution method, and various commercial antifungal su...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dalyan Cilo, Burcu, Ener, Beyza
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2021
Materias:	Infectious Disease
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733416/ https://www.ncbi.nlm.nih.gov/pubmed/35004039 http://dx.doi.org/10.7759/cureus.20220

Ejemplares similares

Species Distribution and Antifungal Susceptibilities of Candida Species Isolated From Blood Culture
por: Dalyan Cilo, Burcu
Publicado: (2023)

Interpretation of Antimicrobial Susceptibility Testing Using European Committee on Antimicrobial Susceptibility Testing (EUCAST) and Clinical and Laboratory Standards Institute (CLSI) Breakpoints: Analysis of Agreement
por: Gaur, Priyanka, et al.
Publicado: (2023)

Comparison of Six Antifungal Susceptibilities of 11 Candida Species Using the VITEK2 AST–YS08 Card and Broth Microdilution Method
por: Lee, Hyeyoung, et al.
Publicado: (2022)

In vitro antifungal susceptibilities of Candida species to liposomal amphotericin B, determined using CLSI broth microdilution, and amphotericin B deoxycholate, measured using the Etest
por: Lovero, Grazia, et al.
Publicado: (2017)

CLSI broth microdilution method for testing susceptibility of Malassezia pachydermatis to thiabendazole
por: Nascente, Patrícia da Silva, et al.
Publicado: (2009)

In Vitro Susceptibility of Candida Species to Four Antifungal Agents Assessed by the Reference Broth Microdilution Method
por: Eksi, Fahriye, et al.
Publicado: (2013)

Microdilution in vitro Antifungal Susceptibility Patterns of Candida Species, From Mild Cutaneous to Bloodstream Infections
por: Rezazadeh, Elham, et al.
Publicado: (2016)

Identification of Candida species and susceptibility testing with Sensititre YeastOne microdilution panel to 9 antifungal agents
por: Kucukates, Emine, et al.
Publicado: (2016)

Antifungal susceptibility profile of Trichosporon isolates: correlation between CLSI and etest methodologies
por: Lemes, Raquel M.L., et al.
Publicado: (2010)

Identification and Antifungal Susceptibility Testing of Candida Species: A Comparison of Vitek-2 System with Conventional and Molecular Methods
por: Kaur, Ravinder, et al.
Publicado: (2016)

Molecular Identification and Antifungal Susceptibility Patterns of Clinical Dermatophytes Following CLSI and EUCAST Guidelines
por: Dabas, Yubhisha, et al.
Publicado: (2017)

Use of the VITEK 2 system to identify and test the antifungal susceptibility of clinically relevant yeast species
por: Melhem, MSC, et al.
Publicado: (2014)

Incidence and Antifungal Susceptibility of Candida Albicans Infections
por: UNGUREANU, A., et al.
Publicado: (2016)

Incremental Healthcare Costs and Outpatient Antifungal Treatment of Patients with Aspergillosis in the United States
por: Durden, Emily, et al.
Publicado: (2013)

Should Preventive Antifungal Treatment Be Given to Patients With Abdominal Contamination in the Intensive Care Unit?
por: Demir Onder, Kubra, et al.
Publicado: (2023)

Antifungal susceptibility testing of Candida species by flow cytometry.
por: Lee, W., et al.
Publicado: (1999)

Candida glabrata susceptibility to antifungals and phagocytosis is modulated by acetate
por: Mota, Sandra, et al.
Publicado: (2015)

Molecular Typing and Antifungal Susceptibility of Candida viswanathii, India
por: Shankarnarayan, Shamanth A., et al.
Publicado: (2018)

Thermogenic Characterization and Antifungal Susceptibility of Candida auris by Microcalorimetry
por: Di Luca, Mariagrazia, et al.
Publicado: (2019)

Susceptibility to echinocandins of Candida spp. strains isolated in Italy assessed by European Committee for Antimicrobial Susceptibility Testing and Clinical Laboratory Standards Institute broth microdilution methods
por: Montagna, Maria Teresa, et al.
Publicado: (2015)

In Vitro Azole and Amphotericin B Susceptibilities of Malassezia furfur from Bloodstream Infections Using E-Test and CLSI Broth Microdilution Methods
por: Rhimi, Wafa, et al.
Publicado: (2020)

Genotyping Analysis of Cryptococcus deuterogattii and Correlation with Virulence Factors and Antifungal Susceptibility by the Clinical and Laboratory Standards Institute and the European Committee on Antifungal Susceptibility Testing Methods
por: Andrade-Silva, Leonardo Euripedes, et al.
Publicado: (2023)

Untargeted antifungal therapy in adult patients with complicated intra-abdominal infection: protocol for a systematic review with meta-analysis
por: Petersen, Marie Warrer, et al.
Publicado: (2017)

Comparative Evaluation of Vitek 2 and Etest versus Broth Microdilution for Ceftazidime/Avibactam and Ceftolozane/Tazobactam Susceptibility Testing of Enterobacterales and Pseudomonas aeruginosa
por: Papadomanolaki, Arhodoula, et al.
Publicado: (2022)

Biofilm Formation and Resistance to Fungicides in Clinically Relevant Members of the Fungal Genus Fusarium
por: Sav, Hafize, et al.
Publicado: (2018)

Antifungal Susceptibility Analysis of Clinical Isolates of Candida parapsilosis in Iran
por: LOTFALI, Ensieh, et al.
Publicado: (2016)

Diversity and antifungal susceptibility of Norwegian Candida glabrata clinical isolates
por: Andersen, Kari-Mette, et al.
Publicado: (2016)

Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern
por: Bitew, Adane, et al.
Publicado: (2018)

Candida blankii: an emergent opportunistic yeast with reduced susceptibility to antifungals
por: Nobrega de Almeida, João, et al.
Publicado: (2018)

Linking Cellular Morphogenesis with Antifungal Treatment and Susceptibility in Candida Pathogens
por: Sharma, Jehoshua, et al.
Publicado: (2019)

Roles of Elm1 in antifungal susceptibility and virulence in Candida glabrata
por: Ito, Yuya, et al.
Publicado: (2020)

Evaluation of antifungal susceptibility in clinical isolates of the Candida glabrata complex
por: Jesus, Filipa, et al.
Publicado: (2021)

Identification and Antifungal Drug Susceptibility Pattern of Candida auris in India
por: Deshkar, Smita, et al.
Publicado: (2022)

Autophagy Alters the Susceptibility of Candida albicans Biofilms to Antifungal Agents
por: Shen, Jiadi, et al.
Publicado: (2023)

Spectrophotometric detection of azole-resistant Aspergillus fumigatus with the EUCAST broth microdilution method: is it time for automated MIC reading of EUCAST antifungal susceptibility testing of Aspergillus species?
por: Meletiadis, Joseph, et al.
Publicado: (2022)

In vitro antifungal susceptibilities of six antifungal drugs against clinical Candida glabrata isolates according to EUCAST
por: Fatahinia, Mahnaz, et al.
Publicado: (2020)

Conventional Amphotericin B Associated Nephrotoxicity in Patients With Hematologic Malignancies
por: Gursoy, Vildan, et al.
Publicado: (2021)

Antifungal Susceptibilities of Bloodstream Isolates of Candida Species from Nine Hospitals in Korea: Application of New Antifungal Breakpoints and Relationship to Antifungal Usage
por: Won, Eun Jeong, et al.
Publicado: (2015)

Antifungal Susceptibility Pattern of Candida glabrata from a Referral Center and Reference Laboratory: 2012–2022
por: Chesdachai, Supavit, et al.
Publicado: (2023)

COVID-19-Associated Pulmonary Aspergillosis Complicated by Severe Coronavirus Disease: Is Detection of Aspergillus in Airway Specimens Before Disease Onset an Indicator of Antifungal Prophylaxis?
por: Kitayama, Takaaki, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qt15r3ins6534kpt0sb07c2lt4